Contrasting pandemic era trajectories of dengue; chikungunya; and hand, foot, and mouth disease in Thailand using national surveillance findings, 2016–2025
- 1Department of Disease Control, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
- 2Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia
- 3Faculty of Medicine, School of Global Health, Chulalongkorn University, Bangkok, Thailand
Abstract
Objectives: To compare the pandemic era trajectories of dengue; chikungunya; and hand, foot, and mouth disease (HFMD) in Thailand
Methods: We conducted a national ecological interrupted time series analysis using weekly surveillance data from all 77 Thai provinces from 2016 to 2025. Segmented quasi-Poisson regression with Fourier terms for annual seasonality estimated the level and slope changes at a calendar-based 2020 break point; sensitivity analyses used later break points.
Results: The analysis included 40579 province-week observations including 790263 dengue, 32265 chikungunya, and 713822 HFMD cases. The estimated level incidence rate ratios at week 1 of the 2020 break point were 0.39 for dengue (95% confidence interval [CI] 0.32-0.48), 0.54 for chikungunya (95% CI 0.41-0.71), and 0.51 for HFMD (95% CI 0.38-0.69). Dengue rebounded above pre-pandemic levels by 2023, chikungunya declined after the 2018-2020 outbreak, and HFMD’s mean annual incidence in 2023–2025 exceeded the pre-pandemic baseline by approximately 26%.
Conclusions: These contrasting trajectories support the need for comparative multi-disease surveillance. Ecological designs cannot separate the contribution of transmission ecology from epidemic history or other time-varying factors.
Related
- Non-identifiability of autochthonous chikungunya risk from surveillance data, Japan, 2011–2025
- Chikungunya resurgence highlights gaps in Aedes surveillance and control in South America
- Contrasting Echocardiographic Trajectories with and Without Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy: A Real-World Observational Study with Two-Dimensional Speckle-Tracking Analysis
- Viral circulation patterns and hospitalisation burden of SARS-CoV-2 and influenza in the post-pandemic period: an analysis of surveillance data from the United States, England and Europe, 2022-2025
- Urine DNA methylation as a potential diagnostic and surveillance tool in non-muscle invasive bladder cancer in Thailand: A pilot study
BibTeX
@article{pongpirul2026contrasting,
title = {{Contrasting pandemic era trajectories of dengue; chikungunya; and hand, foot, and mouth disease in Thailand using national surveillance findings, 2016–2025}},
author = {Wannarat Pongpirul and Mohamed Mustaf Ahmed and Krit Pongpirul},
journal = {IJID regions},
year = {2026},
month = oct,
doi = {10.1016/j.ijregi.2026.101037},
url = {https://europepmc.org/article/PMC/PMC13722057},
note = {CC BY},
}
RIS
TY - JOUR
TI - Contrasting pandemic era trajectories of dengue; chikungunya; and hand, foot, and mouth disease in Thailand using national surveillance findings, 2016–2025
AU - Wannarat Pongpirul
AU - Mohamed Mustaf Ahmed
AU - Krit Pongpirul
PY - 2026
DA - 2026/10/07
JO - IJID regions
DO - 10.1016/j.ijregi.2026.101037
UR - https://europepmc.org/article/PMC/PMC13722057
AB - Objectives: To compare the pandemic era trajectories of dengue; chikungunya; and hand, foot, and mouth disease (HFMD) in Thailand Methods: We conducted a national ecological interrupted time series analysis using weekly surveillance data from all 77 Thai provinces from 2016 to 2025. Segmented quasi-Poisson regression with Fourier terms for annual seasonality estimated the level and slope changes at a calendar-based 2020 break point; sensitivity analyses used later break points. Results: The analysis included 40579 province-week observations including 790263 dengue, 32265 chikungunya, and 713822 HFMD cases. The estimated level incidence rate ratios at week 1 of the 2020 break point were 0.39 for dengue (95% confidence interval [CI] 0.32-0.48), 0.54 for chikungunya (95% CI 0.41-0.71), and 0.51 for HFMD (95% CI 0.38-0.69). Dengue rebounded above pre-pandemic levels by 2023, chikungunya declined after the 2018-2020 outbreak, and HFMD’s mean annual incidence in 2023–2025 exceeded the pre-pandemic baseline by approximately 26%. Conclusions: These contrasting trajectories support the need for comparative multi-disease surveillance. Ecological designs cannot separate the contribution of transmission ecology from epidemic history or other time-varying factors.
SN - 2772-7076
ER -